LifeMD, Inc. — Director's Dealing 2018

Feb 21, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2018-02-13

Reporting Person: McLaughlin Mark (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-13	Common Stock, par value $0.01	D	1130436	$0.23	Disposed	2640507	Direct
2018-02-13	Common Stock, par value $0.01	S	298407	$0.23	Disposed	2342100	Direct
2018-02-13	Common Stock, par value $0.01	S	100000	$0.23	Disposed	1040000	Indirect
2018-02-13	Common Stock, par value $0.01	S	190000	$0.23	Disposed	54228	Indirect
2018-02-13	Common Stock, par value $0.01	D	217391	$0.23	Disposed	512284	Indirect
2018-02-13	Common Stock, par value $0.01	S	5504	$0.23	Disposed	506780	Indirect
2018-02-13	Common Stock, par value $0.01	D	217391	$0.23	Disposed	553284	Indirect
2018-02-13	Common Stock, par value $0.01	S	15000	$0.23	Disposed	538284	Indirect
2018-02-13	Common Stock, par value $0.01	S	31504	$0.23	Disposed	506780	Indirect
2018-02-13	Common Stock, par value $0.01	D	217391	$0.23	Disposed	538362	Indirect
2018-02-13	Common Stock, par value $0.01	S	31582	$0.23	Disposed	506780	Indirect
2018-02-13	Common Stock, par value $0.01	D	217391	$0.23	Disposed	634784	Indirect
2018-02-13	Common Stock, par value $0.01	S	96593	$0.23	Disposed	538191	Indirect
2018-02-13	Common Stock, par value $0.01	S	31410	$0.23	Disposed	506781	Indirect

Footnotes

F1: As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share.

F2: The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

F3: The Reporting Persons beneficially owns shares through a company owned together with his spouse.

F4: These shares were sold in a private transaction to JOJ Holdings, Inc., an entity affiliated with Immudyne's President and Chief Executive Officer, Justin Schreiber, in connection with the transactions contemplated by the Legacy Assets Sale Agreement.

F5: These shares were sold in private transactions in connection with the transactions contemplated by the Legacy Assets Sale Agreement.